Aynur Erşahin

Aynur Erşahin

Auto-generated profile, based on publicly available information

Aynur Erşahin

Department of Obstetrics and Gynecology, Altınbaş University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2020 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Closed access
ÖÇÖnder Çelik
Önder Çelik
ŞHŞafak Hatırnaz
Şafak Hatırnaz
AEAynur Erşahin
Aynur Erşahin
ABAlper Başbuğ
Alper Başbuğ
GYGonca yetkin yıldırım
Gonca yetkin yıldırım
CÜCihat Ünlü
Cihat Ünlü
To investigate whether prior testis magnetic resonance spectroscopy (MRS) predicts the success or failure of micro-dissection testicular sperm extraction (micro-TESE) in patients with non-obstructive azoospermia (NOA). Nine men with NOA who were scheduled for micro-TESE for the first time, 9 NOA men with a history of previous micro-TESE and 5 fertile men were enrolled. All NOA patients and fertile controls underwent testis spectroscopy. A multi-voxel spectroscopy sequence was used. Testicular signals of choline (Cho), creatine (Cr), myo-inositol (MI), lactate, and lipids were analyzed quantitatively and compared with the results of the micro-TESEs. The most prominent peaks were Cho and Cr in the fertile controls and NOA subjects with positive sperm retrieval in the micro-TESE. A high Cho peak was detected in 87% of the NOA men with positive sperm retrieval. NOA men without sperm at the previous micro-TESE showed a marked decrease in Cho and Cr signals. For positive sperm retrieval in micro-TESE, the cut-off value of Cho was 1.46 ppm, the cut-off value of Cr was 1.43 ppm, and the cut-off value of MI was 0.79 ppm. Testis spectroscopy can be used as a non-invasive screening method to predict the success or failure of micro-TESE.

1 August 2019 in ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
Verified
Journal Article
Open access
CŞCoşkun ŞİMŞİR
Coşkun ŞİMŞİR
BCBora Coşkun
Bora Coşkun
BCBuğra COŞKUN
Buğra COŞKUN
AEAynur Adeviye Erşahi̇n
Aynur Adeviye Erşahi̇n
TETolga Ecemi̇ş
Tolga Ecemi̇ş
Aim: To investigate the effects of bacterial vaginosis, which is the most frequent vaginal infection in women, and its treatment on sexual functions.Methods: Patients who had applied to our gynecology outpatient clinic with bacterial vaginosis based on the culture results were included in this observational questionnaire study. Patients with an accompanying disease possibly resulting in sexual dysfunction and those with vaginitis etiology other than bacterial vaginosis were excluded from the study. Patients were asked to fill the Female Sexual Function Index (FSFI) during the diagnosis of bacterial vaginosis and 1 month later than the treatment.Results: Seventy-two patients who had applied to our outpatient clinic between January 2018 and January 2019 and who met the study criteria were included in this study. Statistically significant improvement was found in post-treatment orgasm and pain scores and in total FSFI scores of the patients upon comparison of FSFI scores of patients before and after the treatment (p0.05 for all). Conclusion: It was found that sexual dysfunction was more common in patients with bacterial vaginosis and improvement was seen in some sexual functions with treatment.

3 July 2019 in The European Research Journal
Verified
Journal Article
Open access
PDF file
NGNUR DOKUZEYLÜL GÜNGÖR
NUR DOKUZEYLÜL GÜNGÖR
TGTuğba Gürbüz
Tuğba Gürbüz
AKAyşe Filiz Gökmen Karasu
Ayşe Filiz Gökmen Karasu
AEAynur Erşahin
Aynur Erşahin
Objective: The aim of this study was to investigate whether first trimester combined screening for major fetal trisomies is influenced by assisted reproduction techniques (ART) from blastocyst transfer, with or without cryopreservation.Methods: This study is a retrospective analysis involving 115 singleton pregnancies with euploid fetuses recruited between January 2017 and December 2017. Sixty-five women conceived with fresh blastocysts from in vitro fertilization (IVF) cycles (fresh-blasto), 50 with frozen-thawed blastocysts. All cases underwent ultrasound assessment at 11+0 - 13+6 weeks with measurements of crown rump length, nuchal translucency (NT) , free beta-human chorionic gonadotrophin (free β-hCG) and pregnancy-associated plasma protein A (PAPP-A) concentrations.Results: Baseline characteristics and pregnancy outcomes did not differ substantially among the study groups. The NT was not significantly different in the frozen-thawed -blasto compared to the fresh-blasto group (p = 0.741). The free β-hCG levels was not significantly different in frozen-thawed-blasto group compared to fresh-blasto group (p = 0.495). The two groups showed no significant difference in the PAPP-A levels (p = 0.139). The median delta crown rump length was also not significantly different among the two groups (p = 0.758).Conclusions: In ART pregnancies from blastocyst transfer, with or without cryopreservation, the NT measurement, free β-hCG concentration and PAPP-A levels did not show any significant difference. These features are apparently unrelated to the outcome of pregnancy and may be due to alterations or delays in embryogenesis or placentation with potential relevance for the screening test performance.

15 April 2019 in Adıyaman Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
NGNUR DOKUZEYLÜL GÜNGÖR
NUR DOKUZEYLÜL GÜNGÖR
TGTuğba Gürbüz
Tuğba Gürbüz
AEAynur Erşahin
Aynur Erşahin
SESuat Süphan Erşahin
Suat Süphan Erşahin
ÖYÖzlem Yapıcıer
Özlem Yapıcıer
Ovarian pregnancy (OP) seen quite rarely in ectopic pregnancy (EP). A 29-year-old multigravid woman came us for routine first ultrasound (US) control to see gestational sac (GS) after IUI. Beta-human chorionic gonadotropin (β hCG) amount (10396 mUI/mL) and ultrasound outcomes were doubtful for tubal pregnancy (TP). She has no complaints. Laparoscopy and incision of right ovarian EP were fulfilled. Ovarian pregnancy were approved histologically.

30 April 2021 in Gynecology & Reproductive Health
Verified
Journal Article
Closed access
SESuat Suphan Ersahin
Suat Suphan Ersahin
AEAynur Ersahin
Aynur Ersahin
Objective: To investigate the optimal duration of progesterone therapy before cryopreserved-thawed embryo transfer and its impact on clinical pregnancy and live birth rates. Methods: Five hundreds women undergoing cryopreserved-thawed embryo transfer were included in the study. These patients had a total of 500 embryos frozen on day 3 (n = 200), day 4 (n = 100), day 5 (n = 150) and day 6 (n = 50). Artificial endometrial preparation was successfully performed in all participants. If the endometrial thickness reached a minimum of 8 mm or in the presence of a triple-line view, the patients were divided into four different groups and each group into two subgroups according to the estimated duration of progesterone treatment to be used. Group 1 (n = 200): This group consisted of patients with day 3 embryo transfer. While 100 of 200 patients received embryo transfer after 3 days of progesterone treatment, the remaining 100 patients received embryo transfer after 4 days of progesterone treatment. Group 2 (n = 100): This group consisted of patients who underwent day 4 embryo transfer. While 50 of 100 patients had embryo transfer after 4 days of progesterone treatment, the remaining 50 patients received embryo transfer after 5 days of progesterone treatment. Group 3 (n = 150): This group consisted of patients who received day 5 embryo transfer. While 75 of 150 patients received embryo transfer after 5 days of progesterone treatment, the remaining 75 patients received embryo transfer after 6 days of progesterone treatment. Group 4 (n = 50): While 25 of 50 patients received embryo transfer after 6 days of progesterone treatment, the remaining 25 patients received embryo transfer after 7 days of progesterone treatment. The primary outcome measure of our study was to evaluate clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR), live birth rate (LBR) and miscarriage rate per pregnancy. Results: Clinical pregnancy rates were found in 50 of 100 (50%) cases who were given progesterone for 3 days. Of the 100 cases who were given progesterone for 4 days, 40 clinical pregnancy was detected (40%). Both OPR and LBR were found to be significantly lower in patients who received 4 days of progesterone treatment compared to those given 3 days. The rates of miscarraige (9.09%) in patients who received progesterone treatment for 4 days were significantly higher than those who received progesterone for 3 days (5.8%). In Group 2 both OPR and LBR were found to be significantly lower in patients who received 5 days of progesterone treatment compared to those given 4 days. The rate of miscarraige (25.0%) was significantly higher in patients who received progesterone treatment for 5 days compared to those who received progesterone for 4 days (33.3%). When 75 patients in group III who underwent embryo transfer on the fifth day and received progesterone treatment for 5 days and 75 patients who were given progesterone treatment for 6 days were evaluated in terms of CPR, OPR and LBR the difference was statistically significant between the two gruops. When patients in group IV were evaluated in terms of CPR, OPR and LBR the difference was statistically insignificant. Conclusions: Extending the progestereone usage period one day before embryo transfer has been found beneficial in patients who have been transferred for only fifth day.